Helga Ruebsamen-Schaeff

Effect of Pritelivir ComparedWith Valacyclovir on Genital HSV-2 Shedding in PatientsWith Frequent Recurrences

L. Corey, Meei-Li W Huang, B. Timmler, 2017 .

Safety and Human Pharmacokinetics of AIC316, a Potent Helicase-Primase Inhibitor of Herpes Simplex Virus (HSV)

H. Zimmermann, A. Birkmann, Helga Ruebsamen-Schaeff, 2011 .

Helicase-primase inhibitor pritelivir for HSV-2 infection.

A. Wald, L. Corey, Meei-Li W Huang, 2014, The New England journal of medicine.

The ClpP peptidase of Wolbachia endobacteria is a novel target for drug development against filarial infections.

A. Hoerauf, C. Lentz, Helga Ruebsamen-Schaeff, 2013, The Journal of antimicrobial chemotherapy.

RNA-dependent RNA polymerases from different hepatitis C virus genotypes reveal distinct biochemical properties and drug susceptibilities.

H. Zimmermann, Helga Ruebsamen-Schaeff, J. Kreuter, 2011, Biochimica et biophysica acta.

Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants Selected In Vitro after Letermovir (AIC246) Exposure

H. Zimmermann, Helga Ruebsamen-Schaeff, P. Lischka, 2013, Antimicrobial Agents and Chemotherapy.

InVitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246

H. Zimmermann, Helga Ruebsamen-Schaeff, G. Hewlett, 2010, Antimicrobial Agents and Chemotherapy.

The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase

H. Zimmermann, Helga Ruebsamen-Schaeff, G. Hewlett, 2011, Journal of Virology.